Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

The Trump administration's vaccine advisers are bringing up an old flu-shot debate: Whether it's time to wipe out the last ...

Kennedy's new vaccine advisory committee returned to work Thursday, and the panel may vote on proposals about fall flu ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in ... There were no significant ...

Maria Palen, a fitness enthusiast, faced a devastating health crisis after being diagnosed with babesiosis, a tick-borne ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

Read current news and medical research on influenza A, influenza B, including symptoms, ... Apr. 8, 2025 — Researchers have shown that differences in the entire rotavirus genome ...

Deaths involving influenza have increased in March and April 2025. The first four months of 2025 have recorded 216 deaths involving influenza, higher than 2024 (141 deaths) and 2023 (73 deaths), and ...